New Era of Systemic Therapy for Different Types of Skin Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 September 2026 | Viewed by 67
Special Issue Editor
2. Chemotherapy Sub-Department and One-Day Chemotherapy Department, Specialist Oncological Hospital NU-MED sp. z o. o., 97-200 Tomaszów Mazowiecki, Poland
Interests: skin cancer; melanoma; dermatology
Special Issue Information
Dear Colleagues,
The therapeutic landscape for skin cancers, including basal cell carcinoma, cutaneous squamous cell carcinoma, melanoma, and Merkel cell carcinoma, is undergoing a remarkable transformation. Recent advances in immunotherapy, targeted therapy, and novel biologic agents have revolutionized the management of these malignancies, offering new hope for patients and redefining clinical standards of care. This Special Issue aims to highlight the evolving role of systemic therapies in different types of skin cancer, focusing on their mechanisms of action, clinical efficacy, safety profiles, and integration into multidisciplinary treatment approaches. We welcome submissions that address current challenges and future perspectives, including biomarker discovery, resistance mechanisms, real-world data, and innovative therapeutic combinations. By gathering contributions from both clinical and translational research, this Special Issue seeks to provide a comprehensive overview of the new era of systemic treatment in skin oncology and to foster dialogue that will shape the next generation of therapeutic strategies.
Dr. Magdalena Ciazynska
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- skin cancer systemic therapy
- immunotherapy in skin cancer
- targeted therapy in skin malignancies
- melanoma and nonmelanoma skin cancer
- biomarkers and treatment response
- resistance mechanisms
- combination therapy
- real worldreal-world outcomes
- novel therapeutic agents
- precision oncology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
